Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q1 2014 · 10-Q
Revenue$0.00$0.00— vs Q1 2013 Net Income-$504.88K-$504.88KN/M vs Q1 2013 EPS Diluted-$0.01-$0.01N/M vs Q1 2013 Operating Income-$510,210N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 15, 2014 · 45 d after period end